Company intelligence / Profile preview

Impirica

Alberta, Canada

Ownership: Private
Development stage: Other

Overview

Impirica provides real-time cognitive impairment testing solutions focused on medical, commercial transportation, workplace OHS, law enforcement, and cannabis industries. Its ExceleRATE predictive model identifies individuals at high risk of causing incidents due to cognitive impairment, primarily serving North America.

Therapeutic areas: OtherNeurology
Modalities: DeviceNon-pharmacological therapy
Industry: Digital Health Medical Devices

Partnerships

Research institutes across North America (academic collaborations)

Beyond the preview

Go deeper on Impirica.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Impirica.

Explore the full profile